At first, it was tentative. But now almost all parts of the U.S. healthcare system are racing to adopt some form of ...

Novo Nordisk has a factor VIII mimetic in a phase 3 trial, and a Chinese company is forging ahead with its gene therapy ...

Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

The exact cause of amyotrophic lateral sclerosis (ALS) has long remained a mystery, but new research demonstrates that there ...

In July 2025, the FDA granted priority review for TAR-200 as therapy for patients with high-risk nonmuscle invasive bladder ...

An expert discusses how systemic treatments for vitiligo often have better patient adherence than topical treatments, though ...

Promoting interdisciplinary collaboration via molecular tumor boards and shared decision-making frameworks might improve the ...

Aetna has released the details of its Medicare Advantage plans for 2026, which focus on preventative care and drug cost ...

Humana announces its 2026 Medicare Advantage and prescription drug plans, focusing on stable benefits, preventive care and ...

A remarkably low translation rate of 0.14% of colorectal cancer (CRC) biomarkers have been approved for patient care. The ...

Expedited regulatory paths transform colorectal cancer treatment, enhancing access but creating challenges in clinical evidence and payer decisions.

SCAN Health Plan will expand its 2026 Medicare Advantage benefits with $0 copays and higher dental, vision and allowance ...